î
îŒ
î
Regencell Bioscience Holdings Ltd
RGC11.280USD
-0.400-3.42%
çµå€Â 11/25, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
5.58Bæ䟡ç·é¡
--çŽè¿12ã¶æPER
î
詳现æ å ± Regencell Bioscience Holdings Ltd äŒæ¥å
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Regencell Bioscience Holdings Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãRGC
äŒç€ŸåRegencell Bioscience Holdings Ltd
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOã- -
åŸæ¥å¡æ°12
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jul 16
æ¬ç€Ÿæåšå°11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
éœåž
蚌åžååŒæNASDAQ Capital Market Consolidated
åœHong Kong
éµäŸ¿çªå·- -
é»è©±çªå·85221550823
ãŠã§ããµã€ãhttps://www.regencellbioscience.com/
äŒæ¥ã³ãŒãRGC
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOã- -
Regencell Bioscience Holdings Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
,
,
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
,
,
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Mon, Nov 17
æŽæ°æå»: Mon, Nov 17
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Au (Yat-Gai)
88.56%
Geode Capital Management, L.L.C.
0.08%
Squarepoint Capital LLP
0.01%
ä»ã®
11.35%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Au (Yat-Gai)
88.56%
Geode Capital Management, L.L.C.
0.08%
Squarepoint Capital LLP
0.01%
ä»ã®
11.35%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Individual Investor
88.56%
Investment Advisor/Hedge Fund
0.10%
Research Firm
0.01%
ä»ã®
11.34%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
21
671.84K
0.14%
+311.14K
2025Q2
15
464.50M
93.94%
+23.83M
2025Q1
12
464.34M
93.90%
+23.68M
2024Q4
10
11.60M
89.11%
+20.25K
2024Q3
10
11.58M
89.01%
+24.37K
2024Q2
11
11.57M
88.87%
+5.63K
2024Q1
12
11.56M
88.83%
-17.42K
2023Q4
12
11.57M
88.94%
+13.30K
2023Q3
13
11.56M
88.82%
-12.42K
2023Q2
13
11.55M
88.77%
-36.88K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Au (Yat-Gai)
437.90M
88.56%
+11.47M
+2.69%
Jul 11, 2025
Geode Capital Management, L.L.C.
391.07K
0.08%
+132.06K
+50.99%
Jun 30, 2025
Squarepoint Capital LLP
99.84K
0.02%
+99.84K
--
Jun 30, 2025
Morgan Stanley & Co. LLC
32.42K
0.01%
+32.23K
+16965.79%
Jun 30, 2025
BlackRock Financial Management, Inc.
4.87K
0%
-4.18K
-46.21%
Jun 30, 2025
BNP Paribas Securities Corp. North America
45.05K
0.01%
+45.05K
--
Jun 30, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Thu, Nov 6
æŽæ°æå»: Thu, Nov 6
éæå
æ¯ç
Fidelity Nasdaq Composite Index ETF
0.02%
SPDR S&P China ETF
0.01%
Fidelity Nasdaq Composite Index ETF
æ¯ç0.02%
SPDR S&P China ETF
æ¯ç0.01%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
çš®é¡
æ¯ç
ããŒã¿ãªã
ãããã質å
Regencell Bioscience Holdings Ltdã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îRegencell Bioscience Holdings Ltdã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Au (Yat-Gai)ã¯437.90Mæ ªãä¿æããŠãããããã¯å šäœã®88.56%ã«çžåœããŸãã
Geode Capital Management, L.L.C.ã¯391.07Kæ ªãä¿æããŠãããããã¯å šäœã®0.08%ã«çžåœããŸãã
Squarepoint Capital LLPã¯99.84Kæ ªãä¿æããŠãããããã¯å šäœã®0.02%ã«çžåœããŸãã
Morgan Stanley & Co. LLCã¯32.42Kæ ªãä¿æããŠãããããã¯å šäœã®0.01%ã«çžåœããŸãã
BlackRock Financial Management, Inc.ã¯4.87Kæ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Au (Yat-Gai)ã¯437.90Mæ ªãä¿æããŠãããããã¯å šäœã®88.56%ã«çžåœããŸãã
Geode Capital Management, L.L.C.ã¯391.07Kæ ªãä¿æããŠãããããã¯å šäœã®0.08%ã«çžåœããŸãã
Squarepoint Capital LLPã¯99.84Kæ ªãä¿æããŠãããããã¯å šäœã®0.02%ã«çžåœããŸãã
Morgan Stanley & Co. LLCã¯32.42Kæ ªãä¿æããŠãããããã¯å šäœã®0.01%ã«çžåœããŸãã
BlackRock Financial Management, Inc.ã¯4.87Kæ ªãä¿æããŠãããããã¯å šäœã®0.00%ã«çžåœããŸãã
Regencell Bioscience Holdings Ltdã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îRegencell Bioscience Holdings Ltdã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Au (Yat-Gai)
Geode Capital Management, L.L.C.
Squarepoint Capital LLP
Au (Yat-Gai)
Geode Capital Management, L.L.C.
Squarepoint Capital LLP
Regencell Bioscience Holdings LtdïŒRGCïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ãRegencell Bioscience Holdings Ltdã®æ ªåŒãä¿æããŠããæ©é¢ã¯21瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ671.84Kã§ãå
šäœã®0.14%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-93.80%å¢å ããŠããŸãã
Regencell Bioscience Holdings Ltdã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãRegencell Bioscience Holdings Ltdã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
